Real-World Clinical Practices for Premature Ejaculation: A National Survey of Chinese Physicians.

Authors

Jun Zhu, Gang Ma, Tianbiao Zhang, Xianming Tan, Changwei Yuan, Yuan Tang, Wanshou Cui, Weidong Song, Yiming Yuan, Yifeng Yuan, Zhichao Zhang, Hui Jiang, Jing Peng

Published in

Andrology. Mar 26, 2026. Epub Mar 26, 2026.

Abstract

Premature ejaculation is a prevalent male sexual dysfunction, yet real-world clinical practices in China remain poorly characterized.
To evaluate current premature ejaculation management practices among Chinese physicians.
A nationwide cross-sectional survey of 1000 physicians was conducted using a structured, self-administered questionnaire exploring diagnostic practices, treatment modalities, and perceived therapeutic effectiveness. Associations between physician characteristics and treatment choices were analyzed using chi-square tests.
Diagnostic reliance on clinical history (67.4%) exceeded that on standardized tools (32.6%). Around 46.5% of physicians reported treating intravaginal ejaculation latency time < 1 min without distress, while 32.6% reported treating intravaginal ejaculation latency time > 10 min with distress. Oral dapoxetine (59.7%) and psychotherapy (92.1%) were preferred first-line therapies, followed by long-acting selective serotonin reuptake inhibitors (13.7%). Prescriptions for long-acting selective serotonin reuptake inhibitors were primarily driven by guideline adherence (25.95%), anxiety/depression comorbidity (17.56%), dapoxetine inefficacy (6.11%), and clinician experience (6.11%). Combination therapy was common (52.1%), whereas surgical interventions remained rare (14.7%) but more prevalent among andrologists than among non-andrologists (p < 0.001). Compared with non-andrologists, andrologists demonstrated greater use of behavioral therapy (p = 0.001) and topical agents (p = 0.006) than non-andrologists. Drug selection (54.5%) and psychological factors (16.6%) were identified as key efficacy determinants.
Chinese physicians commonly use combined pharmacological and psychological approaches for premature ejaculation treatment, but significant challenges persist, including inappropriate treatment of non-premature ejaculation cases, unwarranted surgical interventions, and insufficient utilization of evidence-based selective serotonin reuptake inhibitors, highlighting the need for standardized diagnostic criteria and enhanced physician education on guideline-recommended therapies.

PMID:
41884883
Bibliographic data and abstract were imported from PubMed on 26 Mar 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.